Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT00688389 |
Recruitment Status
:
Recruiting
First Posted
: June 2, 2008
Last Update Posted
: March 8, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment |
---|---|
Dengue Fever | Other: case/control |
Study Type : | Observational |
Estimated Enrollment : | 700 participants |
Observational Model: | Case-Control |
Time Perspective: | Other |
Official Title: | Follow-up the Health Condition , Investigation of the Immuno-regulation , and the Study for Interaction of Viral Hepatitis--- Among Patients With or After Dengue Fever Infection |
Study Start Date : | July 2007 |
Estimated Primary Completion Date : | December 31, 2020 |
Estimated Study Completion Date : | December 31, 2020 |

Group/Cohort | Intervention/treatment |
---|---|
healthy |
Other: case/control
case: infected dengue fever people control:healthy people
|
DF |
Other: case/control
case: infected dengue fever people control:healthy people
|
DHF |
Other: case/control
case: infected dengue fever people control:healthy people
|
- 檢查肝臟、腎臟及其他生化功能,並分析宿主免疫調控及血小板變化機致 [ Time Frame: 2007/7/1 ]抽血20 c.c 檢查肝臟、腎臟及其他生化功能,並分析宿主免疫調控及血小板變化機致
Biospecimen Retention: Samples With DNA

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | Child, Adult, Senior |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | Yes |
Sampling Method: | Non-Probability Sample |
Inclusion Criteria:
- Clinical diagnosis of Dengue fever
Exclusion Criteria:

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00688389
Contact: Jih-Jin Tsai, MD | 886-7-312-1101 ext 5677 | jijits@cc.kmu.edu.tw |
Taiwan | |
Kaoshing Medical University Chung-Ho Memorial Hospital | Recruiting |
Kaohsiung, Taiwan | |
Contact: Jih-Jin Tsai, MD 886-7-312-1101 ext 5677 jijits@cc.kmu.edu.tw |
Responsible Party: | Kaohsiung Medical University Chung-Ho Memorial Hospital |
ClinicalTrials.gov Identifier: | NCT00688389 History of Changes |
Other Study ID Numbers: |
KMUH-IRB-960195_1 CB9615 |
First Posted: | June 2, 2008 Key Record Dates |
Last Update Posted: | March 8, 2018 |
Last Verified: | May 2017 |
Keywords provided by Kaohsiung Medical University Chung-Ho Memorial Hospital:
Dengue fever, CLEC5A, Mannose receptor, DC-SIGN, NALP, decoy receptor 3 (DcR3), Toll-like receptors(TLRs), (Nod)-like receptors (NLRs) |
Additional relevant MeSH terms:
Fever Dengue Body Temperature Changes Signs and Symptoms Arbovirus Infections |
Virus Diseases Flavivirus Infections Flaviviridae Infections RNA Virus Infections Hemorrhagic Fevers, Viral |